London +4420 814 42225
Moscow +7495 543 9194
Kiev +38044 599 2950
info@mrcplast.com

Our Clients

Order Informer

 
Home > News >
 

Global medical polymer market estimated to grow at over 50% in 2018

September 24/2013

MOSCOW (MRC) -- The value of the global medical polymer market is set to rise by more than half in the next five years, boosted by an ageing population and developing markets, as per Plastemart with reference to NanoMarkets.

The market is estimated to grow from USUSD2.3 bln to over USUSD3.5 bln, a rise of more than 52%, between now and 2018.

Implants currently consumer around half of the world's medical polymer production and are expected to account for USD1.6 billion in polymer sales by 2018. Lower in cost and lighter than metallic alternatives such as titanium, medical polymers are proving popular among device manufacturers and the medical profession alike.

Sales of polymers destined for diagnostic systems will likely reach around USD1.04 billion in 2018. In vitro diagnostics account for between 50,000 and 60,000 metric tons of specialized and commodity plastics annually.

The report claims that PMMA, PS/styrenics, and PP are the leading medical polymers based on revenue accounting for around 26% of the market in 2013.

There are also some high-value niches appearing in the market. Commercial elastomers that provide a soft touch are being used to coat accessories, such as catheters, gloves, and syringes, in order to impart a soft touch feel. Their use is expected to grow in intravenous drug delivery systems, cardio systems, and blood collection devices.

The last decade has seen the rise of biodegradable polymers. The current trend suggests that in the near future, entire prostheses will be developed from these materials. While they will not be used to manufacture diagnostic products, biodegradable polymers will be incorporated into implants and some clinical labware. There is some additional interest in discovering new biodegradable polymers for medical applications, but investment in this area is limited due to the need to complete extensive long-term studies in order to validate new materials.

We remind that, as MRC informed previously, Styron Europe GmbH, the global materials company and manufacturer of plastics, latex and rubber, has recently appointed Velox GmbH, Hamburg, Germany, as the European distributor for medical product offerings from Styron. Velox, a supplier and marketer of raw materials specialties will represent products for Styron medical applications, including CALIBRE MEGARAD polycarbonate resins and MAGNUM ABS Resins. Besides, in March 2013, Arkema appointed Velox, as its exclusive distributor for the medical business development in Europe.


mrcplast.com
Author:Margaret Volkova
Tags:PP, PS, ABS, polikarbonat, styrene, Medicine, Arkema, Styron.
Category:General News
|
| More

Leave a comment

MRC help

 


 All News   News subscribe